Ori Biotech
Seedtable Score
60
Startups
2
Funding Rounds
3
Investors
$130m
Money raised
Overview
Ori Biotech, based in London, has significant potential due to its focus on improving the manufacturing process for lifesaving treatments. By addressing inefficiencies and delays in traditional methods, Ori Biotech aims to make critical therapies more accessible and timely for patients. The company's advanced technology and specialized manufacturing capabilities set it apart, positioning it to meet growing demands in healthcare. Supported by investors like Kindred Capital and Octopus Ventures, Ori Biotech has the resources needed to disrupt the market and deliver substantial value to its business-to-business clients.
- Website: https://oribiotech.com
- Business model: b2b
- Company size: 1 - 11 employees
- Headquarters: London, UK
- Founded: 2015
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (3)
Octopus Ventures
Climate Tech & Green Tech, Health Tech, Edtech, FinTech, Crypto & web3, ...
DetailsFunding
Funding series
Funding Series Analysis
The company Ori Biotech has raised a total of $130m in funding over 2 rounds.
Key Insights:
- Series B: $100m
- Series A: $30m
Ori Biotech Series A (2020, $30M)
$30m
Ori Biotech Series B (2022, $100M)
$100m